Xiaojuan Ye

No ORCID on file · 1 paper in corpus
review 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1578723

Ovarian cancer(OC) is the second most common gynecological malignancy worldwide. While traditional treatments such as cytoreductive surgery, chemotherapy, and targeted drugs have made progress, patients with advanced disease still face high…